Neko Health, a company that specializes in developing artificial intelligence-powered medical diagnostic tools, has made a significant investment in its preventive screening service. The startup announced today that it has raised $700 million from several major investors, including Lightspeed Venture Partners and O.G. Venture Partners.
The funds will be used to further expand Neko's AI body scans across the United States. The company plans to start operations at a clinic in New York, where patients can undergo a comprehensive examination using its technology. This new addition is part of a series of investments made by Lightspeed Venture Partners and O.G. Venture Partners.
Existing investors have been backing Neko Health for some time, but this latest round gives the company the resources it needs to take its innovative technology further. With its proprietary sensors and AI-powered diagnosis tool, Neko Health claims to be able to accurately detect a wide range of health issues before they become major problems. The company's mission is to revolutionize healthcare by making medical screenings more accurate and efficient.